Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

When it comes to achieving healthy body weight, some men might look to what’s average and use that as their goal. For ...

Since weight-loss drugs that target the hormone GLP-1 have surged in popularity, some additional health benefits have emerged ...

A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...

The blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut down on their alcohol ...

Yet another study is supporting the notion that the blockbuster GLP-1 drug Ozempic can help problems drinkers curb ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise ...

Semaglutide (Wegovy) may help heavy drinkers cut down on their alcohol intake in addition to losing weight, a trial has found ...

Glucagon-like peptide-1 receptor agonist medications for weight loss are significantly transforming the field of facial plastic surgery.

Beyond treating diabetes and helping people lose weight, GLP-1s may also improve libido. But the reasons are as complex as ...